Navigation Links
U.S. Claims Data Show Declining Use of Platform Injectables as Oral Multiple Sclerosis Therapies Gain Traction
Date:11/20/2013

BURLINGTON, Mass., Nov. 20, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through examination of U.S. patient-level claims data, total patient share of platform injectable disease-modifying therapies (DMTs) among recently treated multiple sclerosis (MS) patients declined over four quarters of data collection ending June 30, 2013, with a steeper drop observed in Q2 2013, coinciding with the launch of Biogen Idec's Tecfidera. Quarterly analysis shows that injectable DMTs, namely the interferon betas and Teva's Copaxone, captured a combined 70 percent patient share among recently treated patients in Q2 2013 compared with 80 percent one year earlier. Meanwhile, during the drug's first three months on the market, Tecfidera captured a sizable patient share in this population, approaching the level of Novartis's first-to-market oral DMT Gilenya in this same quarter. These data likely reflect both pent up patient demand for Tecfidera and prescribers' positive opinions of the product's clinical profile compared with other DMTs.

However, the Treatment Algorithms in Multiple Sclerosis report also finds that platform injectables continued to capture a commanding 84 percent of first-line patient share among MS DMTs. Copaxone and Biogen Idec's Avonex were most often prescribed among newly diagnosed MS patients, together capturing over 60 percent of first-line patient share in this population, likely owing to their established advantages in tolerability and delivery, respectively. Thanks to physician comfort and a positive long-term safety record, injectable DMTs maintained a dominant first-line position despite the availability of newer oral alternatives—Gilenya, Tecfidera and Genzyme's Aubagio—which combined to capture only just 6 pe
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims That the Merger May Not Be in the Best Interest of Investors of ViroPharma, Inc. - VPHM
2. Omnicare (NYSE: OCR) Agrees to Pay United States $120 Million to Settle False Claims Act Suit Alleging Kickbacks
3. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AMAG Pharmaceuticals, Inc. -- AMAG
4. Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
5. Stipulation Of Dismissal Of Claims By Plaintiff Cornerstone Biopharma, Inc.
6. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG
7. Specialty pharmacy utilization management programs and 30-day supply claims may improve patient outcomes, reduce waste
8. Bloomberg BNA Publishes Sixth Edition of False Claims Act Treatise
9. FDA Publicly Challenged to Support Unsubstantiated Claims Regarding Electronic Cigarettes
10. SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of MAP Pharmaceuticals, Inc. - MAPP
11. Argus Announces Next Generation Pharmacy Claims Processing Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Nov. 21, 2014  CytoSorbents Corporation (OTCQB: CTSO), ... Union approved CytoSorb® cytokine adsorber to treat critically-ill ... Beacon of Light Award at last night,s New ... Dr. Phillip Chan , Chief Executive ... to be recognized by the New Jersey Tech ...
(Date:11/22/2014)... MEDITE Group acquired by CytoCore, Inc. (OTCBB: CYOE) ... rd quarter sales ended September 30, 2014 of $8.7 ... nine months ended September 2014 and a $38,000 loss for ... quarter is usually a seasonable weak period due to ... for many countries worldwide, we are proud to announce record ...
(Date:11/21/2014)...  Alere Inc. (NYSE: ALR ), a ... Juliet Cunningham as Vice President, Investor Relations. In ... driving communications with the investment community. "As ... to increase shareholder value, it is critical that we ... Chief Executive Officer. "We are delighted that Juliet ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 2CytoCore Inc. / MEDITE Cancer Diagnostics, Inc. Reports Record YTD and 3rd Quarter Sales 3Alere Appoints Juliet Cunningham to Lead Investor Relations 2
... ATLANTA, Nov. 5, 2010 Cimzia® (certolizumab ... moderate to severe rheumatoid arthritis (RA) symptoms, reducing disease ... during the American College of Rheumatology,s 2010 Annual Scientific ... indicated for the treatment of adult patients with moderately ...
... Dendreon Corporation (Nasdaq: DNDN ) today announced that ... Conference, Phoenix, AZ on November 11, 2010 at 1:30 p.m. ... and available for replay from Dendreon,s website, www.dendreon.com . ... it will be archived on the site following the presentation. ...
Cached Medicine Technology:Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 2Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 3Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 4Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 5Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 6Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 7Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 8Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 9Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting 10
(Date:11/23/2014)... 2014 SWAccessControl.com's high quality access control ... the company has announced its new collection of power ... these high quality power suppliers. All the new models ... special offer lasts until Dec. 20, 2014. , SWAccessControl.com ... have been supporting it for a long time. It ...
(Date:11/23/2014)... Beach, CA (PRWEB) November 23, 2014 ... of American Medical Aesthetics & Wellness was recently ... Asher Milgrom, Ph.D. is president and CEO of American ... Dr. Asher Milgrom received a full scholarship to ... and the Medical School at the University of Chicago, ...
(Date:11/23/2014)... 23, 2014 Syngenta lawsuits are now ... of farmers and agribusinesses that have allegedly incurred significant ... Agrisure Viptera and Agrisure Duracade, genetically modified (GMO) ... for sale in China. According to a report from ... ban U.S. corn imports. Because China is the third-largest ...
(Date:11/23/2014)... Lake City, Utah (PRWEB) November 23, 2014 ... individual health insurance reimbursement for small businesses, announced ... new book, The End of Employer-Provided Health Insurance. ... health insurance is the greatest financial risk facing ... challenge facing U.S. employers, small and large, when ...
(Date:11/22/2014)... November 23, 2014 Cancer researchers in ... connection between intercellular communication tunnels and the growth and ... full story on the Surviving Mesothelioma website. ... the University of Minnesota have just released their study ... and materials between cells. They found that mesothelioma ...
Breaking Medicine News(10 mins):Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 2Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 3Health News:Asher Milgrom Is the Founding Doctor of AMA Skincare and Is Featured in the International Business Times 4Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 2Health News:Syngenta Lawsuits Being Investigated by Wright & Schulte LLC, Following China’s Rejection of Corn Shipments Tainted with Unapproved GMO Seed 3Health News:Zane Benefits, Inc. Announces New Webinar on The End of Employer-Provided Health Insurance Now Available On-Demand! 2Health News:Study Links Cellular ‘Tunnels’ to Mesothelioma Proliferation, According to Surviving Mesothelioma 2
... Veterinary Medical,Association (AVMA) today cited the release of ... Inspector General (OIG) report on pre-slaughter,activities in U.S. ... of,food animal veterinarians,( http://www.avma.org/press/releases/080208_nvmsa.asp ) can have dire,consequences ... The OIG report, which was released ...
... access from Internet fraud, Vetted International has implemented a higher level ... ... Raleigh, NC (PRWEB) December xx, 2008 --- Vetted Internationals ... from web fraud . An application upgrade to its ...
... says lack of exposure could also perpetuate more allergies ... Peanut and other food allergies are on the rise, ... life-threatening allergies, and schools are responding by providing nut-free ... schools are going too far, even creating hysteria over ...
... Obama,Administration sets its sights on stabilizing and strengthening ... today called on the transition,team and incoming Treasury ... where action by the Treasury Department is needed ... alcohol content,per serving and the definition of moderate, ...
... than 200 underprivileged,children in Detroit will receive new winter jackets ... annual Holiday Party presented by the Wayne County,Medical Society Foundation ... The New Detroit Science Center at 5020 John R at ... Physicians, medical students, physician spouses and staff ...
... Mich.Dec. 12 The Michigan Legislature,took an important step ... yesterday,by passing House Bill 4146, according to the Michigan ... The bill, introduced by Rep. Frank Accavitti (D-Eastpointe), regulates,tanning ... 18, larger warning signs in tanning facilities listing potential ...
Cached Medicine News:Health News:AVMA Calls for Increased Veterinary Oversight in Meat Production; Cites USDA Audit Report Initiated After Hallmark/Westland Recall 2Health News:AVMA Calls for Increased Veterinary Oversight in Meat Production; Cites USDA Audit Report Initiated After Hallmark/Westland Recall 3Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 2Health News:To Further Combat Internet Fraud, Heightened Security Levels are Implemented by Vetted International 3Health News:Nut Bans in Schools May Be Spurring Hysteria 2Health News:Nut Bans in Schools May Be Spurring Hysteria 3Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 2Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 3Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 4Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 5Health News:Consumer/Health Groups Call for Meaningful Change in How Treasury Department Regulates Alcohol Labeling 6Health News:Dermatologists Applaud Passage of Tanning Salon Regulation 2
... Designed for High Throughput Screening (HTS), ... assays into HTS by sharing all ... of Analyst AD, fluorescence intensity, fluorescence ... Optimized for seamless integration into robotic ...
... highly sensitive time-resolved fluorescence detection by ... These compounds are excited with the ... lifetimes (several hundred microseconds), large Stoke's ... at 620 nm. Therefore with the ...
... most advanced multi-functional microplate detection system, ... performance without compromising flexibility. ,The ... on the Ultra instrument platform. New ... adds to the flexibility of the ...
... is a fully automated microplate based ... measurement principles:, , Fluorescence Polarization ... , High-Performance Luminescence (flash and ... ,It is designed for the widest ...
Medicine Products: